Biotech

All Articles

Innovent links cytokine to colon cancer reactions

.Innovent Biologics has produced the situation that its own checkpoint inhibitor-cytokine combinatio...

Merck, Daiichi ADC attacks goal in period 3 lung cancer cells research study

.A stage 3 test of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate ...

Rakovina strengthens AI concentrate along with collab to decide on cancer aim ats

.Five months after Rakovina Therapies pivoted toward expert system, the cancer-focused biotech has a...

Ascendis' dwarfism medication smash hits in stage 3, threatens BioMarin

.Ascendis Pharma has actually become a prospective threat to BioMarin's Voxzogo, disclosing phase 3 ...

Despite ph. 3 miss, Alkeus finds path ahead of time for eye ailment property

.Though Alkeus Pharmaceuticals' dental eye condition property stopped working to substantially decre...

Kairos goes public with $6M IPO to money trials of cancer cells medicine

.With a trio of biotechs attacking the Nasdaq on Friday, it was simple to skip a smaller-scale socia...

Vaccine and also Keytruda combo reliable in squamous tissue carcinoma

.Immune gate inhibitors are the superheroes of cancer cells treatment. Drugs like Bristol Myers Squi...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of substantial leadership hirings, shootings ...

Regeneron's Opdualag competitor presents 57% reaction cost

.Regeneron is back with long-lasting follow-up for its own LAG-3 inhibitor and PD-1 inhibitor combo ...

AstraZeneca articles information on in-house competitors to AbbVie, Pfizer ADCs

.AstraZeneca has actually discussed an early take a look at the performance of its own in-house anti...